| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.3 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |